151 related articles for article (PubMed ID: 21142218)
21. [Detection of molecular markers of amantadine resistance in swine influenza viruses by pyrosequencing].
Liu H; Lv Y; Huang W; Yan M; Zhang W; Li M; Wang Q; Li J; Zheng D; Zhao Y; Sun C; Wang Z
Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):395-9. PubMed ID: 20499646
[TBL] [Abstract][Full Text] [Related]
22. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
Nguyen H; Le L
Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
[TBL] [Abstract][Full Text] [Related]
23. Understanding molecular mechanisms of traditional Chinese medicine for the treatment of influenza viruses infection by computational approaches.
Gu S; Yin N; Pei J; Lai L
Mol Biosyst; 2013 Nov; 9(11):2696-700. PubMed ID: 23986228
[TBL] [Abstract][Full Text] [Related]
24. New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode.
Rey-Carrizo M; Gazzarrini S; Llabrés S; Frigolé-Vivas M; Juárez-Jiménez J; Font-Bardia M; Naesens L; Moroni A; Luque FJ; Vázquez S
Eur J Med Chem; 2015; 96():318-29. PubMed ID: 25899336
[TBL] [Abstract][Full Text] [Related]
25. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
[TBL] [Abstract][Full Text] [Related]
26. How does influenza virus a escape from amantadine?
Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
[TBL] [Abstract][Full Text] [Related]
27. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
Duwe SC; Wedde M; Birkner P; Schweiger B
Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
[TBL] [Abstract][Full Text] [Related]
28. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001.
Schmidtke M; Zell R; Bauer K; Krumbholz A; Schrader C; Suess J; Wutzler P
Intervirology; 2006; 49(5):286-93. PubMed ID: 16809934
[TBL] [Abstract][Full Text] [Related]
29. [Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].
Rotanov M; Grebennikova TV; Burtseva EI; Shevchenko ES
Mol Gen Mikrobiol Virusol; 2008; (2):27-32. PubMed ID: 18488446
[TBL] [Abstract][Full Text] [Related]
30. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
31. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
Liu H; Yao X; Wang C; Han J
Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
[TBL] [Abstract][Full Text] [Related]
32. Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.
Wang YT; Chan CH; Su ZY; Chen CL
Biophys Chem; 2010 Mar; 147(1-2):74-80. PubMed ID: 20045243
[TBL] [Abstract][Full Text] [Related]
33. Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula.
Dai W; Chen J; Lu P; Gao Y; Chen L; Liu X; Song J; Xu H; Chen D; Yang Y; Yang H; Huang L
Mol Biosyst; 2013 Mar; 9(3):375-85. PubMed ID: 23348248
[TBL] [Abstract][Full Text] [Related]
34. Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.
Arns S; Balgi AD; Shimizu Y; Pfeifer TA; Kumar N; Shidmoossavee FS; Sun S; Tai SS; Agafitei O; Jaquith JB; Bourque E; Niikura M; Roberge M
Eur J Med Chem; 2016 Sep; 120():64-73. PubMed ID: 27187859
[TBL] [Abstract][Full Text] [Related]
35. Antivirals for influenza: historical perspectives and lessons learned.
Hayden FG
Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
[TBL] [Abstract][Full Text] [Related]
36. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(16):433-5. PubMed ID: 19407738
[TBL] [Abstract][Full Text] [Related]
37. Computational and experimental analysis of drug binding to the Influenza M2 channel.
Alhadeff R; Assa D; Astrahan P; Krugliak M; Arkin IT
Biochim Biophys Acta; 2014 Apr; 1838(4):1068-73. PubMed ID: 24016551
[TBL] [Abstract][Full Text] [Related]
38. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.
Huang RB; Du QS; Wang CH; Chou KC
Biochem Biophys Res Commun; 2008 Dec; 377(4):1243-7. PubMed ID: 18996090
[TBL] [Abstract][Full Text] [Related]
39. Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
Schmidtke M; Bauer K; Ludwig N; Wutzler P
Int J Antimicrob Agents; 2008 Aug; 32(2):192-5. PubMed ID: 18571381
[No Abstract] [Full Text] [Related]
40. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
